Glenmark starts Phase-3 clinical trials in india on antiviral drug Favipiravir

Glenmark starts Phase-3 clinical trials in India on antiviral drug Favipiravir Headline Second

Glenmark Pharmaceuticals has said in a statement that they have started Phase-3 clinical trials in India on antiviral tablet Favipiravir,....

Glenmark starts Phase-3 clinical trials in India on antiviral drug Favipiravir Headline Second

Glenmark Pharmaceuticals has said in a statement that they have started Phase-3 clinical trials in India on antiviral tablet Favipiravir,....